Run ID: SRR13837654
Sample name:
Date: 2024-10-05T03:36:27.750951
Number of reads: 293846
Percentage reads mapped: 97.01
Median coverage: 9.0
Strain: lineage4.9
Spoligotype:
Drug-resistance: Sensitive
Lineage | Family | RDs | Frequency |
---|---|---|---|
lineage4 | Euro-American | None | 1.0 |
lineage4.9 | Euro-American (H37Rv-like) | None | 1.0 |
Drug | Resistance | Supporting mutations | WHO confidence | Comment |
---|---|---|---|---|
rifampicin | ||||
isoniazid | ||||
ethambutol | ||||
pyrazinamide | ||||
streptomycin | ||||
fluoroquinolones | ||||
moxifloxacin | ||||
ofloxacin | ||||
levofloxacin | ||||
ciprofloxacin | ||||
aminoglycosides | ||||
amikacin | ||||
capreomycin | ||||
kanamycin | ||||
cycloserine | ||||
ethionamide | ||||
clofazimine | ||||
para-aminosalicylic_acid | ||||
delamanid | ||||
bedaquiline | ||||
linezolid |
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence | Comment |
---|
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence |
---|---|---|---|---|---|---|
rpoB | 761402 | c.1596C>T | synonymous_variant | 1.0 | rifampicin | |
mmpS5 | 778694 | p.Tyr71Ser | missense_variant | 1.0 | bedaquiline | |
clofazimine | ||||||
mmpR5 | 779478 | p.Glu163Asp | missense_variant | 1.0 | bedaquiline | |
clofazimine | ||||||
embR | 1417498 | c.-151G>T | upstream_gene_variant | 1.0 | ethambutol | |
embR | 1417937 | c.-591_-590insA | upstream_gene_variant | 1.0 | ethambutol | |
rrs | 1473125 | n.1280A>T | non_coding_transcript_exon_variant | 1.0 | kanamycin | |
capreomycin | ||||||
streptomycin | ||||||
amikacin | ||||||
rrl | 1475195 | n.1538G>T | non_coding_transcript_exon_variant | 1.0 | capreomycin | |
linezolid | ||||||
fbiA | 3640597 | p.Val19Leu | missense_variant | 1.0 | pretomanid | |
delamanid | ||||||
clofazimine | ||||||
alr | 3840493 | p.Leu310Val | missense_variant | 1.0 | cycloserine | |
embC | 4241184 | p.Thr441Lys | missense_variant | 1.0 | ethambutol | |
embB | 4247920 | c.1407T>C | synonymous_variant | 1.0 | ethambutol |